Carlos Brites

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study

Pedro Cahn, Anton Pozniak, Horacio Mingrone et al. · The Lancet · 2013 · 514 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacotherapy +16

EBV MicroRNAs in Primary Lymphomas and Targeting of <i>CXCL-11</i> by ebv-mir-BHRF1-3

Tianli Xia, Andrea O’Hara, Iguaracyra Araújo et al. · Cancer Research · 2008 · 302 citations · Full text

Life Sciences, Molecular Biology, Oncology +15

Nosocomial Bloodstream Infections in Brazilian Hospitals: Analysis of 2,563 Cases from a Prospective Nationwide Surveillance Study

Alexandre R. Marra, Luís Fernando Aranha Camargo, Antônio Carlos Campos Pignatari et al. · Journal of Clinical Microbiology · 2011 · 268 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons

Colleen F. Kelley, Maribel Acevedo-Quiñones, Allison L. Agwu et al. · New England Journal of Medicine · 2024 · 229 citations

Public Health, Pharmacology, Pharmacotherapy +17

High Zika Virus Seroprevalence in Salvador, Northeastern Brazil Limits the Potential for Further Outbreaks

Eduardo Martins Netto, Andrés Moreira‐Soto, Célia Pedroso et al. · mBio · 2017 · 223 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17